Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Novo Nordisk
BA
bactrian
Community Contributor
A Quality Compounder Marked Down on Overblown Fears
Novo Nordisk , a global leader in diabetes and obesity treatments, is trading at a deep discount to both its historical multiples and intrinsic value. The ADR is now priced at $47.05 , reflecting a normalized P/E ratio of just 13.4× , down from a five-year average closer to 25–30×.
View narrative
US$120.72
FV
57.7% undervalued
intrinsic discount
15.71%
Revenue growth p.a.
Set Fair Value
26
users have liked this narrative
7
users have commented on this narrative
76
users have followed this narrative
New
narrative
ASML Holding
IN
Investingwilly
Community Contributor
Why Now is the Time to buy ASML
What Does ASML Do? ASML Holding N.V. is a Dutch company and the world’s only supplier of extreme ultraviolet (EUV) lithography machines —a critical technology used to produce the world’s most advanced computer chips.
View narrative
US$1.00k
FV
28.0% undervalued
intrinsic discount
15.17%
Revenue growth p.a.
Set Fair Value
35
users have liked this narrative
6
users have commented on this narrative
96
users have followed this narrative
Updated
narrative
Wyndham Hotels & Resorts
ZW
Zwfis
Community Contributor
Wyndham Continues Global Expansion with 19% Ancillary Revenue Growth
WH is a company that I actually took interest in a couple of months ago when I happened to stay at one of their franchise hotels. I had to leave early in the morning at like 4 and when I went out to the parking lot I was astounded that in the little town I was was absolutely full.
View narrative
US$105.80
FV
20.6% undervalued
intrinsic discount
13.23%
Revenue growth p.a.
Set Fair Value
7
users have liked this narrative
2
users have commented on this narrative
15
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Chatham Lodging Trust
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
Asset Recycling Will Reshape US Hotel Portfolios Amid Market Risks
Key Takeaways Asset recycling and technological efficiencies are strengthening portfolio quality, margins, and long-term revenue growth potential in key travel markets. Conservative financial management enhances flexibility for acquisitions and buybacks, while demographic tailwinds support sustained occupancy and rate growth.
View narrative
US$8.67
FV
21.3% undervalued
intrinsic discount
-0.49%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
3 days ago
author updated this narrative
Bank of Marin Bancorp
AN
AnalystConsensusTarget
Consensus Narrative from 5 Analysts
Northern California Expansion And Digital Upgrades Will Secure Banking Stability
Key Takeaways Expansion in growth markets and digital investments are set to boost revenue, efficiency, and client relationships while reducing long-term costs. Strong capital management, conservative underwriting, and a stable deposit base help ensure steady earnings and resilience against funding and credit risks.
View narrative
US$27.00
FV
17.8% undervalued
intrinsic discount
25.57%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
3 days ago
author updated this narrative
Ooma
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
Cloud Migration And Reseller Expansion Will Redefine Digital Communications
Key Takeaways Expanding business subscription revenue and product upgrades are improving recurring income, margins, and earnings visibility, fueled by demand for cloud and POTS-replacement solutions. Growth in targeted industries and geographies, coupled with disciplined innovation and SaaS focus, strengthens Ooma's long-term multi-year revenue and profitability potential.
View narrative
US$17.88
FV
38.1% undervalued
intrinsic discount
5.79%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
3 days ago
author updated this narrative
AngioDynamics
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
Rising Demand For Minimally Invasive Care Will Expand Med Tech
Key Takeaways Growing global demand for minimally invasive therapies, clinical validation, and regulatory progress are set to expand product adoption and boost revenue and margins. International expansion and operational cost savings initiatives will diversify revenue streams, reinforce profitability, and drive sustained growth across key Med Tech segments.
View narrative
US$18.25
FV
53.4% undervalued
intrinsic discount
6.61%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
6
users have followed this narrative
3 days ago
author updated this narrative
America's Car-Mart
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
Digital Payments And Data Analytics Will Expand Auto Finance
Key Takeaways Leveraging analytics, digital tools, and diverse payment options to improve credit quality, reduce losses, and enhance customer experience supports stronger margins and earnings stability. Expansion in inventory, financing, and market reach amid used car industry constraints positions the company for resilient growth and improved competitive standing.
View narrative
US$62.50
FV
31.3% undervalued
intrinsic discount
6.84%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
3 days ago
author updated this narrative
Bioventus
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
Minimally Invasive Nonopioid Pain Management Will Expand With PNS
Key Takeaways Launch of innovative pain management devices and strong growth across diverse product lines position the company for sustained revenue and margin expansion. Operational efficiencies combined with favorable market trends and payer support drive improved profitability and long-term growth momentum.
View narrative
US$12.75
FV
45.7% undervalued
intrinsic discount
5.07%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
3 days ago
author updated this narrative
Peakstone Realty Trust
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
Accelerated Transformation To Industrial Outdoor Storage Will Deliver Superior Returns
Key Takeaways Strategic portfolio shift to industrial outdoor storage assets and active office disposals strengthens long-term earnings potential, operating margins, and capital efficiency. Lower redevelopment costs and effective deleveraging improve financial flexibility, supporting faster growth and positioning for acquisition opportunities.
View narrative
US$14.67
FV
17.6% undervalued
intrinsic discount
-1.73%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
3 days ago
author updated this narrative
Theravance Biopharma
AN
AnalystConsensusTarget
Consensus Narrative from 5 Analysts
Clinical Milestones And Patent Extensions Will Secure Future Expansion
Key Takeaways Accelerating demand for key respiratory therapies and strong royalty income support sustained revenue growth and improved earnings visibility. Strategic focus on targeted therapies, intellectual property protection, and operational efficiency boosts margins and long-term earnings stability.
View narrative
US$17.20
FV
33.0% undervalued
intrinsic discount
26.70%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
3 days ago
author updated this narrative
Global Medical REIT
AN
AnalystConsensusTarget
Consensus Narrative from 8 Analysts
Discounted Outpatient Properties Will Unlock Healthcare Real Estate Potential
Key Takeaways Acquisition of outpatient medical properties below market rates and successful re-tenanting are expected to drive rent, occupancy, and earnings growth. Favorable healthcare demographics and disciplined capital management are supporting stable demand, higher margins, and sustained long-term value creation.
View narrative
US$9.09
FV
27.8% undervalued
intrinsic discount
3.53%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
6
users have followed this narrative
3 days ago
author updated this narrative
Value any company in seconds
Popular companies